DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+13.41%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.21B
AUM Growth
+$2.21B
(+22%)
Cap. Flow
+$176M
Cap. Flow
% of AUM
7.94%
Top 10 Holdings %
Top 10 Hldgs %
38.16%
Holding
100
New
15
Increased
24
Reduced
25
Closed
9
Top Buys
| 1 |
McKesson
MCK
|
$63.5M |
| 2 |
DexCom
DXCM
|
$57.3M |
| 3 |
Viatris
VTRS
|
$56M |
| 4 |
Glaukos
GKOS
|
$53.9M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$46.5M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$73.6M |
| 2 |
Gilead Sciences
GILD
|
$66.4M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$62.2M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$28M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$26.4M |
Sector Composition
| 1 | Healthcare | 76.44% |
| 2 | Financials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Select Medical
SEM
$1.6B
| $22.9M | 1.03% |
2,217,194
+1,280,597
| +137% | +$13.2M |
|
|
PDCO
27
DELISTED
Patterson Companies, Inc.
PDCO
| $21.9M | 0.99% |
566,000
+172,738
| +44% | +$6.68M |
|
|
SYRS
28
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $18.7M | 0.84% |
126,895
| – | – |
|
29
Molina Healthcare
MOH
$9.6B
| $17.7M | 0.8% |
258,000
+106,335
| +70% | +$7.31M |
|
30
Cartesian Therapeutics
RNAC
$267M
| $17.4M | 0.78% |
31,721
-3,612
| -10% | -$1.98M |
|
|
AAC
31
DELISTED
AAC Holdings, Inc.
AAC
| $17.2M | 0.78% |
1,733,276
-242,071
| -12% | -$2.4M |
|
|
SCTL
32
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $17.1M | 0.77% |
2,120,379
| – | – |
|
33
Synlogic
SYBX
$17.4M
| $16.2M | 0.73% |
+56,676
| New | +$16.2M |
|
|
PTLA
34
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $16.1M | 0.73% |
298,545
-120,455
| -29% | -$6.51M |
|
35
eHealth
EHTH
$126M
| $16.1M | 0.72% |
672,994
-17,354
| -3% | -$415K |
|
|
OXFD
36
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $15.9M | 0.72% |
945,710
| – | – |
|
|
LOXO
37
DELISTED
Loxo Oncology, Inc
LOXO
| $15.6M | 0.7% |
169,000
-82,167
| -33% | -$7.57M |
|
38
Ardelyx
ARDX
$1.57B
| $15.4M | 0.69% |
2,746,480
+466,700
| +20% | +$2.61M |
|
|
AAAP
39
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $14.7M | 0.66% |
218,000
-174,904
| -45% | -$11.8M |
|
|
NEOS
40
DELISTED
Neos Therapeutics, Inc
NEOS
| $14.4M | 0.65% |
1,568,921
+109,726
| +8% | +$1M |
|
|
BPMC
41
DELISTED
Blueprint Medicines
BPMC
| $14.1M | 0.64% |
203,000
| – | – |
|
42
Agios Pharmaceuticals
AGIO
$2.36B
| $13.9M | 0.63% |
+208,000
| New | +$13.9M |
|
43
CytomX Therapeutics
CTMX
$350M
| $13.8M | 0.62% |
756,822
| – | – |
|
|
EPZM
44
DELISTED
Epizyme, Inc
EPZM
| $13.3M | 0.6% |
700,526
+38,157
| +6% | +$727K |
|
45
Galapagos
GLPG
$2.06B
| $13.2M | 0.6% |
130,000
-57,501
| -31% | -$5.85M |
|
46
Wave Life Sciences
WVE
$1.27B
| $12.6M | 0.57% |
580,000
-166,841
| -22% | -$3.63M |
|
47
Xencor
XNCR
$594M
| $12M | 0.54% |
522,000
-40,236
| -7% | -$922K |
|
48
argenx
ARGX
$44.2B
| $11.5M | 0.52% |
509,022
| – | – |
|
|
ALPN
49
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $10.8M | 0.49% |
933,100
-3
| -0% | -$35 |
|
|
IVTY
50
DELISTED
Invuity, Inc
IVTY
| $10.5M | 0.47% |
1,177,229
| – | – |
|